Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

New combinations comprising modafinil reported by Cephalon

Jan. 31, 2005

Small-particle suspensions of anticonvulsant, antidementia and immunosuppressive agents

Jan. 31, 2005

AL-108 enters phase I trials for Alzheimer's disease

Jan. 31, 2005

GB Therapeutics acquires CHF-1512 for Parkinson's disease

Jan. 31, 2005

New therapies for Parkinson's disease claimed by Roche

Jan. 28, 2005

New opioid analgesics described in a Euroceltique patent

Jan. 28, 2005

Alnylam initiates program to develop RNAi therapeutics for spinal cord injury

Jan. 28, 2005

MT-100 recommended for approval in U.K.

Jan. 28, 2005

Group III mGluRs agonist shows promise in the treatment of neuropathic pain

Jan. 28, 2005

Nociceptin analogues described in patent literature

Jan. 27, 2005

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...